Skip to main content

Table 4 Shift from baseline to end-point (LOCF) in percentile distribution of body weight

From: Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance

End Point Percentile Category (LOCF) Baseline Percentile Category, n (%)
≤5 > 5- ≤ 10 > 10- ≤ 25 > 25- ≤ 50 > 50- ≤ 75 > 75- ≤ 90 > 90- ≤ 95 > 95 Total
≤5 22 (73.3) 1 (11.1) 1 (2.3) 0 0 0 0 0 24 (9.6)
> 5- ≤ 10 6 (20.0) 3 (33.3) 5 (11.6) 0 0 0 0 0 14 (5.6)
> 10- ≤ 25 1 (3.3) 3 (33.3) 17 (39.5) 8 (17.4) 0 0 0 0 29 (11.6)
> 25- ≤ 50 1 (3.3) 2 (22.2) 19 (44.2) 19 (41.3) 9 (15.0) 0 0 0 50 (19.9)
> 50- ≤ 75 0 0 1 (2.3) 16 (34.8) 29 (48.3) 3 (10.3) 0 0 49 (19.5)
> 75- ≤ 90 0 0 0 3 (6.5) 22 (36.7) 14 (48.3) 3 (20.0) 1 (5.3) 43 (17.1)
> 90- ≤ 95 0 0 0 0 0 9 (31.0) 6 (40.0) 2 (10.5) 17 (6.8)
> 95 0 0 0 0 0 3 (10.3) 6 (40.0) 16 (84.2) 25 (10.0)
Total 30 (100.0) 9 (100.0) 43 (100.0) 46 (100.0) 60 (100.0) 29 (100.0) 15 (100.0) 19 (100.0) 251 (100.0)